Concept:
Chronic Hepatitis B Virus (HBV) infection follows a dynamic natural history categorized by the European Association for the Study of the Liver (EASL) and AASLD into distinct clinical phases based on viral replication, immune activity, and liver necroinflammation.
The immunotolerant phase is typically seen in children and young adults who acquired HBV through vertical (perinatal) transmission.
Explanation:
• Phase 1: Immune-Tolerant Phase (HBeAg-Positive Chronic Infection):
- Characterized by high levels of active viral replication (HBV DNA $>10^7\text{ IU/mL$}) and positive HBsAg and HBeAg.
- The immature host immune system does not mount a cytotoxic T-lymphocyte response against infected hepatocytes; hence, there is minimal hepatocyte damage, resulting in persistently normal Alanine Aminotransferase (ALT) levels and absent or minimal liver fibrosis.
• Phase 2: Immune-Reactive Clearance Phase (HBeAg-Positive Chronic Hepatitis):
- Active host immune response attacks infected cells; marked by high/fluctuating HBV DNA, positive HBeAg, and elevated ALT with active histological inflammation.
• Phase 3: Inactive Carrier Phase (HBeAg-Negative Chronic Infection):
- HBsAg positive, HBeAg negative, anti-HBe positive, low or undetectable HBV DNA ($<2000\text{ IU/mL}$), and normal ALT.
• Phase 4: HBeAg-Negative Chronic Hepatitis:
- Precore or basal core promoter mutant strains; HBsAg positive, anti-HBe positive, fluctuating high HBV DNA, and elevated ALT.
Final Answer:
The immunotolerant phase of chronic HBV is defined by HBsAg (+), HBeAg (+), very high serum HBV DNA, and normal ALT levels.